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Abstract. Breast cancer is one of the world's leading cause of death in women. Due to the 
resistance of chemotherapeutic agents, there is a continuous need to search of natural 
products with anticancer activity.  The use of natural products  is expected to increase the 
effectiveness  and decrease side effect. The purpose of this study was to investigate the 
anticancer activity of ethanol extract of andaliman fruits (EEAF) towards 4T1 cells. 
Extracts were prepared by maceration using solvent ethanol 96%. 4T1 cells were grown in 
culture medium DMEM then given by EEAF and doxorubicin. Cytotoxic test in vitro was 
done by MTT method [3-(4,5-dimetiltiazol-2-il) -2.5 difeniltetrazolium bromide] which is 
then analyzed using SPSS 21. The results from this study showed that the cytotoxic results 
(IC50) after treatment with EEAF and doxorubicin were 54.48 ± 0.22 µg/mL dan 0.80 ± 
0.02 µg/mL.Based on the result above, we conclude that EEAF has cytotoxic activity 
towards 4T1 cancer cells. 
  
Keywords: andaliman fruits, Zanthoxylum acanthopodium DC., ethanol extract, breast 
cancer, 4T1 cell line. 
Abstrak. Kanker payudara merupakan salah satu penyebab kematian terbesar di dunia 
pada wanita. Resistensi agen kemoterapi menyebabkan perlu dilakukannya pencarian 
bahan alam dengan aktivitas antikanker. Penggunaan bahan alam diharapkan dapat 
meningkatkan efektivitas dan menurunkan efek samping. Tujuan penelitian ini untuk 
mengetahui aktivitas antikanker ekstrak etanol buah andaliman (EEBA) terhadap sel 4T1. 
Ekstrak diperoleh melalui maserasi dengan menggunakan pelarut etanol 96%. Sel 4T1 
dibiakkan dalam media kultur DMEM kemudian diberi EEBA dan doksorubisin sebagai 
kontrol positif. Pengujian sitotoksik secara in vitro menggunakan metode MTT [3-(4,5-
dimetiltiazol-2-il)-2,5 difeniltetrazolium bromida] yang kemudian dianalisis menggunakan 
SPSS 21. Hasil uji sitotoksik (IC50) yang diperoleh setelah pemberian EEBA dan 
doksorubisin sebesar 54,48 ± 0,22 µg/mL dan 0,80 ± 0,02 µg/mL. Berdasarkan hasil 
diatas, dapat disimpulkan bahwa EEBA memiliki aktivitas sitotoksik terhadap sel kanker 
4T1. 
 
Kata kunci: buah andaliman, Zanthoxylum acanthopodium DC., ekstrak etanol, kanker 
payudara, sel 4T1   
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1.  Introduction 
The world health organization (WHO) reported that breast cancer is one of the leading cause of 
death and the most common cancer type amongst women worldwide in 2012  [1]. Moreover, 
breast cancer ranks as the fifth cause of death from cancer overall (522,000 deaths), is the most 
frequent cause of cancer death in women in less developed countries (324,000 deaths, 14.3% of 
total), and the second cause of cancer death in developed countries (198,000 deaths, 15.4%) 
after lung cancer [2]. The diversity of medicinal plants in Indonesia is one of chances in 
potential development of Indonesia in the globalization era [3], [4]. The use of medicinal plant 
extracts for the treatment of human disease is an ancient practice and thus has greatly increased 
in recent years.  
Traditionally, andaliman fruits (Zanthoxylum acanthopodium DC.) has been used as aromaticum 
substances, tonicum,  and treat dysentery. Indian people have used andaliman to treat paralyzed 
and skin disease such as abscess and leprosy. Andaliman has been used as spices at North 
Sumatera especially at North Tapanuli [5], [6], [7]. The plants from Zanthoxylum genus contain 
many compounds such as phenol hydroquinones, flavonoids, steroids/triterpenoids, tannins, 
glycosides, volatile oils, alkaloids, coumarines, lignans, amides and terpenes [8], [9], [10], [11], 
[12], [13], [14], [15]. Ethylacetate extract of andaliman fruits (EEA) was showed to have 
cytotoxicity effect against MCF-7 and T47D cell lines. EEA was found to have synergistic 
effect when combined with doxorubicin. EEA was showed to have anticancer activity towards 
mices induced  with benzo(a)pyrene, having cardioprotective effect and active on T47D 
resistance cells [16], [17], [18]. 
The aim of this study was to determine cytotoxicity activity of ethanol extract  of Zanthoxylum 
acanthopodium DC. fruits on 4T1 cells. 
2.  Materials and Methods 
2.1  Materials 
Fresh fruits of Zanthoxylum acanthopodium DC. was collected from Onan Rungu village, 
Samosir regency, Sumatera Utara Province, Indonesia. Zanthoxylum acanthopodium DC. was 
identified in Research Centre for Biology, Indonesian Institute of Science, Bogor, and the 
voucher specimen was deposited in herbarium with number of 
332/IPH.1.01/If.07/II/2016, DMSO (Merck), [3-(4,5-dimethylthiazole-2-yl)-2,5-diphenyl 
tetrazolium bromide] (MTT) (Sigma). 
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2.2  Preparation of ethanol extract  
The air-dried and powdered fruits of Zanthoxylum acanthopodium DC. (1 kg) was extracted by 
cold maceration with ethanol 96% (3x3 d, 7.5 L). The filtrate was collected, and then 
evaporated under reduced pressure to give a viscous extract and then freeze dried to give a dried 
extract [4], [19]. 
2.3  Cytotoxicity assay 
EEAF was submitted for cytotoxicity test. In that way, 4T1 cell line was grown in DMEM 
medium containing 10% FetaL Bovine Serum (Gibco), 1% penicillin-streptomycine (Gibco), 
and fungizone 0.5% (Gibco) in a flask in a humidified atmosphere (5% CO2) at 37oC. The 
inoculums seeded at 1 x 104 cells/mL at an optimal volume of 0.1 mL per well. After 24 h 
incubation, the medium was discharged and treated by EEAF. After incubation for 24 h, the 
cells were incubated with 0.5 mg/mL MTT for 4 h at 37oC. Viable cells reacted with MTT to 
produce purple formazan crystals. After 4 h, SDS 10% as stopper (Sigma) in 0.01N HCl 
(Merck) was added to dissolve the formazan crystals. The cells were incubated for 24 h in room 
temperature and protected from light. After incubation, the cells were shaken, and absorbance 
was measured using microplate reader at λ 595 nm. The data which were absorbed from each 
well were converted to percentage of viable cells [19], [20]. 
The equation to determine viability of cells: 
𝑽𝒊𝒂𝒃𝒊𝒍𝒊𝒕𝒚 =  
𝑨𝒃𝒔 𝒐𝒇 𝒕𝒓𝒆𝒂𝒕𝒎𝒆𝒏𝒕 − 𝑨𝒃𝒔 𝒐𝒇 𝒎𝒆𝒅𝒊𝒖𝒎
𝑨𝒃𝒔 𝒐𝒇 𝒄𝒐𝒏𝒕𝒓𝒐𝒍 𝒄𝒆𝒍𝒍𝒔 − 𝑨𝒃𝒔 𝒐𝒇 𝒎𝒆𝒅𝒊𝒖𝒎
 𝒙 𝟏𝟎𝟎% 
3.  Results and Discussion 
3.1 Cytotoxicity Effect of EEAF 
This research was aimed to investigate of EEAF for its cytotoxicity effect on 4T1 cell lines. 
MTT method was used to determine cell viability after incubation for 24 h. In the treatment  was 
showed the inhibit of cells growth. The IC50 value was shown on Table 1. 
Table 1. The IC50 value of EEAF and doxorubicin 
Treatment Nilai IC50 (µg/mL) 
EEAF 54.48 ± 0.22 
Doxorubicin 0.80 ± 0.02 
 
Based on the result from statistical analysis using SPSS 21 the IC50 value of EEAF towards 4T1 
cell was 54.48 ± 0.22 µg/mL and doxorubicin 0.80 ± 0.02 µg/mL. The active extract should 
have IC50 value in range 10 - 100 µg/mL [21]. The cytotoxicity estimate of natural product is 
related to content of active compounds in these plants including Zanthoxylum acanhopodium 
DC. Flavonoids, alkaloids, saponins and tannins estimated as active compounds [16], [22]. This 
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extract could be develope into co-chemotherapy agent which using together with conventional 
chemotherapy agents. Doxorubicin has cytotoxicity activity with inhibits synthesis od DNA and 
RNA through topoisomerase II. In clinical doxorubicin is effective to threat breast cancer 
patients with metastatic [23].  
4.  Conclusion 
The results reveal that ethanol extract of Zanthoxylum acanthopodium DC. fruit potential to 
treat breast cancer.  
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